Metraipolis › archive › dc_bc4d35ce786a

Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies — Europe PMC PMID:42797500

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42797500
DOI
10.3390/ph19091455
License (as archived)
solo-consultazione
Archived
2026-10-08T17:18:31.594Z
SHA-256 of the archived text
3e6c7d27d993f62519da6ce0e0dcac7f24904e65b954eebd7b12564394e01e17
Stable URL of this page
https://metraipolis.com/documento/dc_bc4d35ce786a

How to cite

Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies — Europe PMC PMID:42797500 — Europe PMC (en), https://europepmc.org/article/MED/42797500 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc4d35ce786a (Metraipolis archive dc_bc4d35ce786a, sha256 3e6c7d27d993f62519da6ce0e0dcac7f24904e65b954eebd7b12564394e01e17)
BibTeX
@misc{dcbc4d35ce786a,
  title = {Therapeutic Resistance in Melanoma: Molecular Mechanisms and Emerging Pharmaceutical Strategies — Europe PMC PMID:42797500},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42797500},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc4d35ce786a; sha256 3e6c7d27d993f62519da6ce0e0dcac7f24904e65b954eebd7b12564394e01e17},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797500. Agents can read the archived copy with the MCP tool read_document.